What is the treatment for chicken pox (varicella)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Chicken Pox (Varicella)

Oral acyclovir is the primary treatment for chicken pox (varicella) in high-risk individuals, with dosing of 20 mg/kg (maximum 800 mg) 4 times daily for 5 days, ideally started within 24 hours of rash onset. 1, 2, 3

Treatment Approach Based on Patient Population

Healthy Children Under 12 Years

  • Symptomatic treatment is usually adequate for otherwise healthy children under 12 years of age 1
  • Supportive care includes:
    • Antipyretics for fever (avoid aspirin due to risk of Reye syndrome) 1
    • Antihistamines or topical calamine lotion for pruritus 4
    • Maintaining adequate hydration 3

High-Risk Individuals (Treatment Indicated)

  • Oral acyclovir should be considered for:
    • Persons aged >12 years 1
    • Individuals with chronic cutaneous or pulmonary disorders 1
    • Persons receiving long-term salicylate therapy 1
    • Persons receiving short, intermittent, or aerosolized courses of corticosteroids 1
    • Secondary household contacts of infected children 1

Dosing Recommendations

  • Children (2 years and older): 20 mg/kg per dose orally 4 times daily (80 mg/kg/day) for 5 days 3
  • Children over 40 kg and adults: 800 mg 4 times daily for 5 days 3
  • Treatment should be initiated within 24 hours of rash onset for maximum effectiveness 3, 5

Immunocompromised Patients

  • Intravenous acyclovir is indicated for varicella-zoster infections in immunocompromised patients 3
  • Recommended dosage: 10 mg/kg IV every 8 hours 2
  • Duration of treatment typically 7-10 days depending on clinical response 6

Special Considerations

Pregnant Women

  • Acyclovir is classified as a Category B drug in pregnancy 1
  • Routine use is not recommended for pregnant women with uncomplicated varicella 1
  • In cases of serious complications (e.g., pneumonia), intravenous acyclovir should be considered 1
  • A registry of acyclovir use during pregnancy showed no increased risk of birth defects 3

Post-Exposure Prophylaxis

  • For susceptible high-risk individuals exposed to varicella:
    • Varicella zoster immune globulin (VZIG) should be administered within 96 hours of exposure 1
    • Vaccination is the method of choice for healthy susceptible individuals after exposure 1
    • Acyclovir is not indicated for prophylactic use among otherwise healthy individuals 1

Important Clinical Pearls and Pitfalls

  • Early treatment is crucial - acyclovir must be started within 24 hours of rash onset for maximum effectiveness 3, 5
  • Adequate hydration should be maintained during treatment 3
  • Monitor renal function in patients receiving acyclovir, especially those with pre-existing renal impairment 3
  • Dosage adjustment is necessary for patients with renal impairment 3
  • Avoid contact with susceptible individuals until all lesions have crusted over 1
  • Vaccination is the preferred method for prevention of varicella in susceptible individuals 1

Monitoring and Follow-up

  • Monitor for signs of bacterial superinfection (increasing erythema, warmth, tenderness, purulent drainage) 4
  • Secondary bacterial skin infections may require antibiotic therapy 4
  • Most cases resolve without complications within 1-2 weeks 1
  • Patients with severe disease or complications should be hospitalized for close monitoring and intravenous therapy 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamiento de la Varicela

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Therapeutic approach to chickenpox in children and adults--our experience.

Medical archives (Sarajevo, Bosnia and Herzegovina), 2012

Research

Antiviral treatment in chickenpox and herpes zoster.

Journal of the American Academy of Dermatology, 1988

Research

Chickenpox in adults - clinical management.

The Journal of infection, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.